rho GTPase Activating Protein 36 (ARHGAP36) (N-Term) Peptid
ARHGAP36
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle ARHGAP36 Produkte
- ARHGAP36 (rho GTPase Activating Protein 36 (ARHGAP36))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- KPDRALPIDR PNTLDKWFLI LRGQQRAVSH KTFGISLEEV LVNEFTRRKH
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-RP13-102H20.1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ARHGAP36 (rho GTPase Activating Protein 36 (ARHGAP36))
- Hintergrund
-
RP13-102H20.1 is the GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.
Alias Symbols: FLJ30058
Protein Size: 547 - Molekulargewicht
- 62 kDa
- Gen-ID
- 158763
- NCBI Accession
- NM_144967, NP_659404
- UniProt
- Q6ZRI8
-
Sie sind hier:
